|
|
|
Insider
Information: |
Hesslein Robert W. |
Relationship: |
Senior VP & General Co... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
102,200 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$831,908 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
102,200 |
|
|
Total
Value |
$831,908 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-42.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Foundation Medicine, Inc. |
FMI |
SVP and General Counsel |
2018-07-31 |
0 |
|
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
Senior VP & General Co... |
2023-03-20 |
102,200 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2018-04-01 |
4 |
A |
$78.75 |
$678,904 |
D/D |
8,621 |
106,964 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2016-07-05 |
4 |
S |
$18.26 |
$23,190 |
D/D |
(1,270) |
107,061 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2018-04-02 |
4 |
S |
$74.88 |
$118,685 |
D/D |
(1,585) |
107,723 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2016-07-01 |
4 |
S |
$17.39 |
$59,735 |
D/D |
(3,435) |
108,331 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2018-04-02 |
4 |
OE |
$7.12 |
$16,689 |
D/D |
2,344 |
109,308 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2023-02-13 |
4 |
AS |
$7.67 |
$21,998 |
D/D |
(2,868) |
109,907 |
0 |
% |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2021-04-05 |
4 |
S |
$4.95 |
$16,295 |
D/D |
(3,292) |
110,056 |
0 |
% |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-01-04 |
4 |
S |
$18.49 |
$26,367 |
D/D |
(1,426) |
110,536 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2016-04-01 |
4 |
A |
$18.25 |
$821,250 |
D/D |
45,000 |
111,766 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-01-03 |
4 |
S |
$17.41 |
$56,687 |
D/D |
(3,256) |
111,962 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2023-01-17 |
4 |
AS |
$9.57 |
$21,549 |
D/D |
(2,188) |
112,775 |
0 |
% |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
113,348 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2022-04-04 |
4 |
AS |
$8.25 |
$22,985 |
D/D |
(2,786) |
114,963 |
0 |
% |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2016-10-04 |
4 |
S |
$23.65 |
$28,853 |
D/D |
(1,220) |
115,218 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2018-01-02 |
4 |
S |
$64.00 |
$119,296 |
D/D |
(1,864) |
116,364 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2016-08-09 |
4 |
OE |
$4.16 |
$48,255 |
D/D |
9,377 |
116,438 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2022-03-21 |
4 |
AS |
$8.29 |
$41,100 |
D/D |
(4,955) |
117,749 |
0 |
% |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-10-02 |
4 |
S |
$38.80 |
$84,002 |
D/D |
(2,165) |
118,228 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-05-12 |
4 |
S |
$33.87 |
$34,175 |
D/D |
(1,009) |
118,430 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-05-01 |
4 |
A |
$35.80 |
$585,939 |
D/D |
16,367 |
119,439 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-07-06 |
4 |
S |
$38.84 |
$196,919 |
D/D |
(5,070) |
120,393 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2022-02-17 |
4 |
AS |
$3.55 |
$14,555 |
D/D |
(4,100) |
122,704 |
0 |
% |
|
FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
|
2017-06-08 |
4 |
OE |
$4.16 |
$36,196 |
D/D |
7,033 |
125,463 |
0 |
- |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2022-02-11 |
4 |
AS |
$3.36 |
$10,927 |
D/D |
(3,252) |
126,804 |
0 |
% |
|
VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
|
2022-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
130,056 |
0 |
- |
|
50 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|